Table 2.
The correlation of other cardiovascular risk factors with cystatin C or eGFRcystatin C/eGFRcreatinine ratio
| Variable | Cystatin Ca | eGFRcystatin C/eGFRcreatinine ratio | ||
|---|---|---|---|---|
|
|
|
|||
| r | P value | r | P value | |
| Age | 0.374 | <0.001 | −0.231 | <0.001 |
|
| ||||
| Cystatin Ca | 1.000 | - | −0.674 | <0.001 |
|
| ||||
| Creatininea | 0.527 | <0.001 | 0.184 | <0.001 |
|
| ||||
| HbA1c | −0.086 | 0.012 | 0.145 | <0.001 |
|
| ||||
| Total cholesterola | −0.080 | 0.019 | 0.080 | 0.019 |
|
| ||||
| Triglyceridea | 0.101 | 0.003 | −0.019 | 0.575 |
|
| ||||
| HDL-cholesterola | −0.172 | <0.001 | 0.111 | 0.001 |
|
| ||||
| Intima-media thickness | 0.114 | 0.001 | −0.021 | 0.541 |
|
| ||||
| Ankle-brachial index | −0.047 | 0.166 | 0.063 | 0.065 |
|
| ||||
| baPWV | 0.355 | <0.001 | −0.155 | <0.001 |
|
| ||||
| Pulse pressure | 0.241 | <0.001 | −0.149 | <0.001 |
|
| ||||
| Uric acid | 0.414 | <0.001 | −0.175 | <0.001 |
|
| ||||
| Calculated ASCVD risk | 0.365 | <0.001 | −0.081 | <0.001 |
eGFR, estimated glomerular filtration rate; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; baPWV, brachial-ankle pulse wave velocity; ASCVD, atherosclerotic cardiovascular disease.
Data were transformed logarithmically to a normal distribution: cystatin C, creatinine, total cholesterol, and HDL-cholesterol.